SCHEMBL985760

SCHEMBL985760

CCCCCCCCC(CCCCCC)c1cccc(O)c1C(C)(C)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYSLTR2 Q9NS75 1/20 0.42
CYSLTR1 Q9Y271 1/20 0.42
SLC37A4 O43826 1/20 0.36
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35
ATM Q13315 1/20 0.35
BID P55957 3/20 0.35
MCL1 Q07820 3/20 0.35
BCL2L1 Q07817 2/20 0.35
BAK1 Q16611 2/20 0.35
KAT8 Q9H7Z6 2/20 0.35
NAAA Q02083 1/20 0.35
PPARG P37231 1/20 0.35
PPARA Q07869 1/20 0.35
EP300 Q09472 1/20 0.35
KAT2A Q92830 1/20 0.35
KAT2B Q92831 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL984904 1.00 CYSLTR2 (0.42) CYSLTR2CYSLTR1SLC37A4ALDH1A1MEN1
SCHEMBL981529 1.00 CYSLTR2 (0.42) CYSLTR2CYSLTR1SLC37A4ALDH1A1MEN1
SCHEMBL984340 1.00 CYSLTR2 (0.42) CYSLTR2CYSLTR1SLC37A4ALDH1A1MEN1
SCHEMBL981579 1.00 CYSLTR2 (0.42) CYSLTR2CYSLTR1SLC37A4ALDH1A1MEN1
SCHEMBL980869 1.00 CYSLTR2 (0.42) CYSLTR2CYSLTR1SLC37A4ALDH1A1MEN1
SCHEMBL983547 1.00 CYSLTR2 (0.42) CYSLTR2CYSLTR1SLC37A4ALDH1A1MEN1
SCHEMBL982935 1.00 CYSLTR2 (0.42) CYSLTR2CYSLTR1SLC37A4ALDH1A1MEN1
SCHEMBL981720 1.00 CYSLTR2 (0.42) CYSLTR2CYSLTR1SLC37A4ALDH1A1MEN1
SCHEMBL982513 1.00 CYSLTR2 (0.42) CYSLTR2CYSLTR1SLC37A4ALDH1A1MEN1
SCHEMBL983660 1.00 CYSLTR2 (0.42) CYSLTR2CYSLTR1SLC37A4ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2275406-B1 PROCESS FOR PRODUCING ISOCYANATE ASAHI CHEMICAL IND (JP) 2018-11-28 EP disclosed
US-9233918-B2 Isocyanate production process ASAHI KASEI CHEMICALS CORPORATION (JP) 2016-01-12 US disclosed
US-20110092731-A1 ISOCYANATE PRODUCTION PROCESS ASAHI KASEI CHEMICALS CORPORATION (JP) 2011-04-21 US disclosed
EP-2275406-A1 PROCESS FOR PRODUCING ISOCYANATE Asahi Kasei Chemicals Corporation (JP) 2011-01-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110092731-A1 ISOCYANATE PRODUCTION PROCESS CPS1, PHGDH, APEH CYSLTR2 1058/4885CYSLTR1 1784/4885SLC37A4 4375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.